Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease (K-ELUVIA Registry)
Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease (K-ELUVIA Registry)
Enrollment (day 0):
1) Written consent
Post PTA (Day 1 ~3):
Symptom: Rutherford class
Adverse event
Ankle-brachial index
Laboratory test: - eGFR, Cr, ALT, AST
Concomitant medication
Regular Follow-up Visits
Visit 1 (post-PTA 30±14 days):
Symptom: Rutherford class
Physical examination
Concomitant medication
Adverse event
Laboratory test:
Visit 2 (post-PTA 6 months ± 30 days):
Visit 3 (post-PTA 12 months ± 30 days): (Mandatory)
Symptoms: Rutherford class
Physical examination
Ankle-brachial index
Duplex ultrasound, CT, or catheter angiography
Concomitant medication
Adverse event 7) Biplane radiograph of femur for evaluation of stent fracture 8) Laboratory test: - AC glucose, eGFR, Cr, ALT, AST
Inclusion Criteria:
Exclusion Criteria: